Recently Added |View More
Working at Roswell Park will afford you incredible opportunities to work alongside some of the nation’s foremost clinicians and researchers to broaden your career experiences and be part of a team that eases the burden of cancer.
Clinical Trial Offers CAR T-Cell Therapy Targeting MUC16 for Recurrent/Refractory Ovarian Cancer
Roswell Park Comprehensive Cancer Center is one of only four sites in the U.S. and the only one in New York State offering a phase 1 clinical trial of an investigational cellular therapy strategy for the treatment of recurrent or refractory ...
Roswell Park Researchers to Discuss Recent Discoveries and Critical Issues in Oncology at AACR 2025
Researchers from Roswell Park Comprehensive Cancer Center will report their latest findings to colleagues from around the world at the 2025 annual meeting of the American Association for Cancer Research (AACR) in Chicago, Illinois, April 25-30.
Join Roswell Park's Experts at NCCN
Roswell Park invites you to meet some of our leading experts in oncology and patient care at the National Comprehensive Cancer Network's 2025 Annual Meeting in Orlando, FL, on March 28-30.
Join Roswell Park’s Surgical Experts at SSO
2025 Society of Surgical Oncology Annual Meeting in Tampa, FL, on March 27-29.
Advances in Ovarian Cancer Treatment Show Promise for Longer Response, Survival Rates
While it remains the leading cause of death among patients with gynecologic cancers, new treatments are offering patients better outcomes and better quality of life.
Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park
Congressman Kennedy announced $7,731,872 in funding for the Roswell Park Comprehensive Cancer Center to renovate its newly integrated biobank, the Roswell Park Biorepository, made possible through the Office of the Director of the National ...
New Clinical Trials for Cervical Cancer Now Available at Roswell Park
Groundbreaking new treatments, including a handful of clinical trials, are now available for patients at Roswell Park Comprehensive Cancer Center, says gynecologic oncologist Karen McLean, MD, PhD, FCAOG.
Immunotherapies, Antibody Drug Conjugants Among Advances in Endometrial Cancer Treatment Options
While the majority of endometrial cancer cases are diagnosed early and patients have an excellent prognosis, those diagnosed with advanced or recurrent endometrial cancer often face a worse prognosis and their treatment can be more difficult.
This site is intended for healthcare professionals
Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.